| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 31-Dec-08 | | Total Revenue | 47,043 | 43,805 | 39,664 | 33,756 | | Cost of Revenue | 30,144 | 27,937 | 25,024 | 21,607 | | | Gross Profit | 16,899 | 15,868 | 14,640 | 12,149 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 15,511 | 14,643 | 13,680 | 13,435 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 60 | 153 | 367 | 5,321 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,328 | 1,072 | 593 | (6,607) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 57 | 26 | 91 | 276 | | Earnings Before Interest And Taxes | 1,385 | 1,098 | 684 | (6,331) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 1,385 | 1,098 | 684 | (6,331) | | Income Tax Expense | 604 | 469 | 1,363 | (2,854) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 781 | 629 | (679) | (3,477) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 781 | 629 | (679) | (3,477) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $781 | $629 | ($679) | ($3,477) |
|
0.02% Nasdaq 
Income Statement
